NCT05741242: A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Sponsor: Jaime Leandro Foundation for Therapeutic Cancer Vaccines. Phase: PHASE1. Conditions: Cancer, Solid Tumor